Denali Filter-Femoral Delivery System
Medical device recall Z-1069-2016. Published in FDA’s Enforcement Report on Mar 16, 2016.
No Watch here, and no alerts: openFDA asks that its enforcement data “should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall” (openFDA). For FDA’s own recall emails, subscribe at FDA. FDA’s own record is on accessdata.fda.gov.
The short answer
Published in FDA’s Enforcement Report on Mar 16, 2016. Copied from openFDA on Oct 20, 2026.
- Class II FDA’s class
- Terminated its status, in FDA’s file
- Nationwide FDA’s word, and 49 states named
- 3572 how much, in FDA’s words
Every line below is in FDA’s own words, with its source beside it. FDA’s terms are explained in FDA’s own words.
How serious is it, by FDA’s class?
Class II, the middle of FDA’s three classes.
“Products that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.”
openFDA, in plain words, its enforcement report fields.
“Class II is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
FDA’s rule, 21 CFR 7.3(m)(2), eCFR.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
What’s wrong with it?
Bard Peripheral Vascular, Inc. is recalling Denali Filter-Jugular/Subclavian Delivery System and Denali Filter-Femoral Delivery System because of the stop cocks potentially cracking.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Which ones are recalled?
Denali Filter-Femoral Delivery System Product Code: DL900F/DL950F; Indicated for use in the prevention of recurrent pulmonary embolism via placement in the vena cava.
3572, in FDA’s words.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Codes to check against yours
Product # Lot # DL900F GFZJ0276 DL900F GFZJ0278 DL900F GFZJ0277 DL900F GFZJ0279 DL900F GFZJ0421 DL900F GFZJ0425 DL900F GFZJ0430 DL900F GFZJ0432 DL900F GFZJ0429 DL950F GFZJ0223 DL900F GFZJ0433 DL900F GFZJ0434 DL950F GFZJ1174 DL900F GFZJ0436…
Every code shown here, 1,087 characters
Product # Lot # DL900F GFZJ0276 DL900F GFZJ0278 DL900F GFZJ0277 DL900F GFZJ0279 DL900F GFZJ0421 DL900F GFZJ0425 DL900F GFZJ0430 DL900F GFZJ0432 DL900F GFZJ0429 DL950F GFZJ0223 DL900F GFZJ0433 DL900F GFZJ0434 DL950F GFZJ1174 DL900F GFZJ0436 DL900F GFZJ0435 DL900F GFZJ0442 DL900F GFZJ0443 DL900F GFZK0287 DL900F GFZJ0446 DL900F GFZK0291 DL900F GFZK0288 DL900F GFZJ0444 DL900F GFZK0290 DL900F GFZK0289 DL900F GFZK0292 DL900F GFZK0294 DL900F GFZK0296 DL900F GFZK0293 DL900F GFZK0294 DL900F GFZK0297 DL900F GFZK0295 DL900F GFZK0299 DL900F GFZK0298 DL900F GFZK0300 DL900F GFZK0301 DL900F GFZK0302 DL900F GFZK0351 DL900F GFZK0352 DL900F GFZK0356 DL900F GFZK0355 DL900F GFZK0357 DL900F GFZK0337 DL900F GFZK0354 DL900F GFZK0338 DL900F GFZK0364 DL900F GFZK0339 DL950F GFZK2368 DL900F GFZK3526 DL900F GFZK0367 DL900F GFZK3527 DL900F GFZK3524 DL900F GFZK3525 DL900F GFZK0328 DL900F GFZK0330 DL900F GFZK0331 DL900F GFZK0332 DL900F GFZK0333 DL900F GFZK0334 DL900F GFZK3523 DL900F GFZK0336 DL900F GFZK0335 DL900F GFZK3528 DL900F GFZK3529 DL900F GFZK3530 DL900F GFZK3538 DL900F GFZK3543 DL950F GFZK2369
Copied exactly as FDA lists them: lot and serial numbers, dates and other codes on the product or its label.
Where did it go?
FDA’s words for the “general area of initial distribution”: where the firm first shipped it.
Worldwide Distribution-US (nationwide) including DC and PR, and the states of MN, TX, PA, OH, IL, OR, CA, SC, NC, AK, NY, MD, GA, NJ, AZ, KY, OH, WI, AL, AR, MO, FL, MA, MT, TN, LA, CT, NE, WV, VA, NV, ME, UT, CO, WY, AR, DE, NM, IN, MN, MS, NH, IA, MI, WA, VA, KS, HI, RI, SD, VT, and the countries of Hong Kong, Malaysia, Canada, Chile.
The states and territories these words name
49 states and territories.
Every one of them
- Alaska
- Alabama
- Arkansas
- Arizona
- California
- Colorado
- Connecticut
- District of Columbia
- Delaware
- Florida
- Georgia
- Hawaii
- Iowa
- Illinois
- Indiana
- Kansas
- Kentucky
- Louisiana
- Massachusetts
- Maryland
- Maine
- Michigan
- Minnesota
- Missouri
- Mississippi
- Montana
- North Carolina
- Nebraska
- New Hampshire
- New Jersey
- New Mexico
- Nevada
- New York
- Ohio
- Oregon
- Pennsylvania
- Puerto Rico
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Virginia
- Vermont
- Washington
- Wisconsin
- West Virginia
- Wyoming
What FDA means by nationwide
“The term “nationwide” is defined to mean the fifty states or a significant portion. Note that subsequent distribution by the consignees to other parties may not be included.”
openFDA, its enforcement report fields.
The words say it went outside the United States too.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
Is it still going on?
Terminated, in FDA’s file.
“FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.”
openFDA, on “Terminated”, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
- The firm began the recall on Feb 9, 2016.
- FDA classified it on Mar 8, 2016.
- FDA’s Enforcement Report published it on Mar 16, 2016.
- FDA terminated it on May 13, 2016.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Who is recalling it?
- Bard Peripheral Vascular Inc, of Tempe, AZ.
- Who began it, in FDA’s words: Voluntary: Firm initiated.
- How the firm first told its customers: Letter.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
What this record can’t tell you
- Whether your own one is affected: compare the codes, dates and numbers above with yours. When unsure, ask the firm or the store.
- Where it went after the firm’s first shipments. FDA’s words cover the firm’s initial distribution, and, in FDA’s words, “subsequent distribution by the consignees to other parties may not be included.”
- How many have been returned, corrected or destroyed: FDA’s report doesn’t say.
- Whether anyone was hurt or fell ill: the report doesn’t say.
- How current it is: openFDA publishes FDA’s Enforcement Report weekly, after FDA does, and a firm can announce a recall weeks before it appears there. openFDA’s own caution: “This data should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall.”
- A product with no recall here isn’t safe by that: FDA’s report lists the recalls FDA classified, and when.
Hearth Record wrote these lines; the quotations are FDA’s.
Sources
-
U.S. Food and Drug Administration, Device recall enforcement reports.
Released Oct 14, 2026 and checked Oct 20, 2026. Updated weekly. Public domain (CC0 1.0, openFDA). FDA asks that nothing suggest it endorses this site.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.” Copied on Oct 20, 2026.